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Abstract
Introduction—Most successfully resuscitated cardiac arrest patients do not survive to hospital
discharge. Many have withdrawal of life sustaining therapy (WLST) as a result of the perception
of poor neurologic prognosis. The characteristics of these patients and differences in their postarrest care are largely unknown.
Methods—Utilizing the Penn Alliance for Therapeutic Hypothermia Registry, we identified a
cohort of 1311 post-arrest patients from 26 hospitals from 2010 to 2014 who remained comatose
after return of spontaneous circulation. We stratified patients by whether they had WLST postarrest and analyzed demographic, arrest, and post-arrest variables.
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Results—In our cohort, 565 (43%) patients had WLST. In multivariate regression, patients who
had WLST were less likely to go to the cardiac catheterization lab (OR 0.40; 95% CI: 0.26–0.62)
and had shorter hospital stays (OR 0.93; 95% CI: 0.91–0.95). When multivariate regression was
limited to patient demographics and arrest characteristics, patients with WLST were older (OR
1.18; 95% CI: 1.07–1.31 by decade), had a longer arrest duration (OR 1.14; 95% CI: 1.05–1.25
per 10 min), more likely to be female (OR: 1.41; 95% CI: 1.01–1.96), and less likely to have a
witnessed arrest (OR 0.65; 95% CI: 0.42–0.98).
Conclusion—Patients with WLST differ in terms of demographic, arrest, and post-arrest
characteristics and treatments from those who did not have WLST. Failure to account for this
variability could affect both clinical practice and the interpretation of research.
Keywords
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Cardiopulmonary resuscitation; Heart arrest; Brain; Epidemiology; Prognosis

Introduction
Individuals who suffer cardiac arrest experience high rates of morbidity and mortality. Even
when patients survive the initial arrest event, prognosis can be poor.1,2 Until the last few
decades, it was assumed that the chances of regaining meaningful functional neurologic
recovery in survivors who remained comatose post-arrest were low. However, with the use of
more aggressive bundles of care focusing on targeted temperature management (TTM) and
hemodynamic optimization, outcomes are improving, and more patients are discharged from
the hospital with meaningful neurologic recovery.3–5
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Despite these advances, most post-cardiac arrest patients suffer some degree of anoxic brain
injury.6 This brain injury, or at least the expectation of it, is a common cause of death for
post-arrest patients.7,8 The majority of successfully resuscitated post-arrest patients who
remain comatose die after withdrawal of life-sustaining therapies (WLST) based on a
presumed poor neurologic outcome.7,9–11 This is appropriate for patients with nonrecoverable neurologic injuries, but post-arrest prognosis is difficult and it often takes many
days post-arrest to determine outcomes.6,8 Indeed, remaining comatose post-arrest may lead
patients to have WLST earlier than recommended for an “adequate” neuroprognostic
decision to be made.9,10

Author Manuscript

Although guidelines address the need for neuroprognostication in WLST decision-making,
the specific factors potentially influencing the decision to pursue WLST remain
incompletely explored. To address this gap in knowledge, we sought to characterize the
demographic, arrest, and post-arrest factors associated with WLST in post-arrest patients.

Methods
This is a retrospective cohort study utilizing data from the Penn Alliance for Therapeutic
Hypothermia (PATH) Registry. The PATH registry is a national, online repository for patient
data from multiple centers utilizing TTM in the management of post-cardiac arrest patients.
This was a multi-center study evaluating patient data from 27 institutions and was approved
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by the University of Pennsylvania Institutional Review Board with a waiver of informed
consent.
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We identified adult comatose post-arrest patients between 2010–2014 from the PATH
registry with information on do not resuscitate (DNR) orders and WLST. Patients were
excluded if they were not successfully resuscitated post-cardiac arrest, if they were younger
than 18 years of age, and if they had missing information on DNR status or outcome at
hospital discharge. Patient demographic data including age, race and sex were compiled. The
following patient comorbidities were abstracted: acute stroke or transient ischemic attack,
chronic obstructive pulmonary disease (COPD), coronary artery disease (CAD), dementia,
diabetes mellitus (DM), end stage renal disease (ESRD), hypertension, metastatic or hematologic cancer, peripheral vascular disease (PVD), HIV/AIDS, and congestive heart failure
(CHF). Finally, arrest variables (location of arrest, suspected etiology, initial pulseless
rhythm, and duration of arrest), and post-arrest variables (whether the patient received TTM,
had documented neurology or cardiology consultations, went to the cardiac catheterization
laboratory, went to the electrophys-iology laboratory, had electroencephalography (EEG)
performed, had a computerized tomography (CT) scan of the head or brain Magnetic
Resonance Imaging (MRI), had echocardiography performed, and the length of hospital
stay) were collected for each patient. The primary outcome, WLST, was documented in the
chart by the attending critical care physician and was defined not simply as change in code
status, but as the decision to actively withdraw supportive therapies and provide comfort
measures only.
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Differences in categorical variables by primary outcome (WLST versus no WLST) were
analyzed using Chi-square tests. Continuous variables were checked for normality using the
skewedness and kurtosis test for normality and then analyzed using a Mann–Whitney U test
to compare the differences in medians by group. To analyze the relationship between
patient- and arrest-level variables and WLST, a multivariate logistic regression model was fit
using demographic and arrest factors in order to assess how these variables contribute to
WLST. Covariates were included in this model if they had a p-value ≤ 0.2512,13 and removed
from the model using backward elimination using Stata 12.1 (College Station, TX). Potential
effect modifiers were examined and model fit was examined both with and without the
interaction term(s). In order to evaluate the relationship between post-arrest care modalities
and WLST while controlling for patient-level variability, a series of logistic regressions were
fit controlling for the relevant demographic and arrest characteristics, as determined by the
previous analysis. Tests for trend across ordered groups was performed to assess changes in
rates of WLST by year and changes in percentage of WLST performed prior to 72 h postarrest by year. As this was a multi-center study, post-estimation likelihood ratio tests were
performed to evaluate the extent of clustering by site.
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Results
Of 1311 patients meeting inclusion criteria, 565 (43%) patients had WLST. These patients
differed in demographic, arrest, and post-arrest characteristics and treatments (Table 1).
Patients with WLST were more likely to be older, female, have an unwitnessed arrest, have
an initial non-shockable rhythm, and have longer duration of arrest. They were more likely

Resuscitation. Author manuscript; available in PMC 2018 January 01.

Grossestreuer et al.

Page 4

Author Manuscript

to have an EEG performed and to have a shorter hospital length of stay. They were less
likely to have TTM performed, a consultation from the cardiology service, go to the cardiac
catheterization lab, have an MRI of the brain, or have echocardiography performed. In terms
of comorbidities, patients with WLST were statistically more likely to have COPD, CAD,
DM, hypertension, PVD, metastatic cancer, and CHF, but statistically less likely to have a
history of acute stroke or transient ischemia attack. The median length of stay was
significantly longer in the patients without WLST (WLST: 2 [IQR: 1, 5] days; no-WLST: 10
[IQR: 2, 17]; Fig. 1).
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When multivariate regression was limited to patient demographics and arrest characteristics
(age, race, sex, whether the arrest was witnessed, duration of arrest, an interaction between
etiology of arrest and initial rhythm), patients with WLST were older (OR 1.18; 95% CI:
1.07–1.31 by decade), had a longer duration of arrest (OR 1.14; 95% CI: 1.05–1.25 for each
additional 10 min of pulselessness), were more likely to be female (OR: 1.41; 95% CI: 1.01–
1.96), and were less likely to have a witnessed arrest (OR 0.65; 95% CI: 0.42–0.98). In
multivariate regression analysis controlling for the same demographic and arrest
characteristics as well as the year of arrest, patients who had WLST were less likely to go to
the cardiac catheterization lab (OR 0.40; 95% CI: 0.26–0.62), and had shorter hospital stays
(OR 0.93; 95% CI: 0.91–0.95 by day).
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Information on timing of WLST was available in 553/565 (97.9%) patients with WLST.
294/553 (53.2%) of patients who had WLST had it occur in the first 48 h post-arrest (“early
WLST”; Table 2). Patients with early WLST were more likely to be older, white, female,
and have an initial non-shockable rhythm, a non-cardiac etiology of arrest, an in-hospital
cardiac arrest, and a longer duration of arrest. They were less likely to have an
electroencephalogram (EEG) performed, receive targeted temperature management (TTM)
or a consultation from the cardiology or neurology service, go to the cardiac catheterization
lab, have a head CT, or have echocardiogra-phy performed. In terms of comorbidities,
patients with early WLST only differed from those without in that they were statistically less
likely to have a history of acute stroke or transient ischemia attack (TIA). The median length
of stay was significantly shorter in the patients with early WLST (1 [IQR: 0, 1] day vs. 8
[IQR: 3, 16] days).

Author Manuscript

When multivariate regression was limited to patient demographics and arrest characteristics
(age, race, sex, whether the arrest was witnessed, duration of arrest, etiology of arrest, and
initial rhythm), patients with early WLST were older (OR 1.34; 95% CI: 1.19–1.50 by
decade), had a longer duration of arrest (OR 1.12; 95% CI: 1.03–1.21 for each additional 10
min of pulselessness), were more likely to be female (OR: 1.54; 95% CI: 1.08–2.21), were
less likely to have a shockable initial rhythm (OR: 0.43; 95% CI: 0.28–0.66) and were less
likely to be African–American (OR 0.56; 95% CI: 0.36–0.87). In multivariate regression
analysis controlling for the same demographic and arrest characteristics as well as the year
of arrest and for clustering by hospital, patients who had early WLST were less likely to be
treated with targeted temperature management (OR: 0.37; 95% CI: 0.21–0.63) to have a
neurology consultation (OR: 0.31; 95% CI: 0.20–0.47), to have a cardiology consultation
(OR: 0.35; 95% CI: 0.20–0.62), go to the cardiac catheterization lab (OR 0.29; 95% CI:
0.17–0.50), have a head CT (OR: 0.27; 95% CI: 0.15–0.50), have echocardiography
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performed (OR: 0.20; 95% CI: 0.13–0.30), and have EEG performed (OR: 0.24; 95% CI:
0.13–0.45). We compared demographic and arrest characteristics in patients by timing of
WLST/death in non-survivors (first 2 days, days 3–7, and after day7) and in survivors and
found no clear systematic differences or trends (Supplemental Table S1 in the online version
at DOI:http://dx.doi.org/10.1016/j.resuscitation.2016.10.021). We also limited the
population to OHCAs and found little change in associations in most univariate and
multivariate analyses (Supplemental Tables S2 and S3 in the online version at DOI:http://
dx.doi.org/10.1016/j.resuscitation. 2016.10.021). Of note, the associations between race and
sex in the early WLST group were no longer significant, and OHCA patients with early
WLST were found to receive significantly fewer brain MRIs.
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There was a significant trend toward increased rates of WLST by year (Fig. 2). However,
there was no significant difference in the rates of WLST prior to 72 h post-arrest by year.
Our statistical evaluation of clustering by site did not yield evidence of any changes in
association.

Discussion

Author Manuscript

Our findings show that, in adjusted analysis, patients with withdrawal of life-sustaining
therapies were older and more likely to be female, have a longer duration of arrest, and to
have had an unwitnessed arrest. They were also more likely to have certain comorbidities:
COPD, CAD, DM, hypertension, PVD, metastatic cancer, and CHF. This analysis clearly
outlines that patients with WLST have different characteristics than those that do not.
Additionally, in patients with WLST, those with “early WLST” were older and more likely
to be female, have a longer duration of arrest, have an initial non-shockable rhythm, and less
likely to be African–American than those with later WLST. They were also less likely to
have experienced an acute stroke or TIA. Whether this is the effect of provider bias or the
result of pathophysiologic difference cannot be inferred from this study; however, our
analysis accounted for physiologic difference between cohorts.
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Our results are similar to a recent publication looking at early WLST versus late WLST
post-arrest. This study found that 52% of comatose post-arrest patients had WLST and that
the decision to withdraw these therapies was influenced by age, race, preexisting
comorbidities, multi-organ failure, and a poor initial neurologic exam.14 Although we did
not investigate the effect of multi-organ failure or the initial neurologic exam, we did find
similar results for age, with older patients more likely to have WLST and more likely to
have early WLST. We did not find a statistically signifi-cant relationship between race and
WLST, but we did find that a larger proportion of patients who had WLST versus no WLST
were white (72.7% vs. 67.0%), a trend that was reversed in African Amer-ican patients
(21.9% vs. 25.0%) (p = 0.08). Although not statistically significant, this trend does allude to
a possible racial disparity in the utilization of WLST. Additionally, African Americans were
significantly less likely to have WLST in the first 48 h. In contrast to the above work, which
found no difference between patients with certain cormorbidities,14 we found that patients
with certain comorbidities (specifically, those with COPD, CAD, DM, hypertension, PVD,
metastatic cancer, and CHF) were more likely to have WLST, a difference that could be
explained by comparative sample sizes.
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Looking at the utilization of withdrawal of life-sustaining therapy is of vital importance in
post-arrest care—it is not only prevalent,11 but also variable. A study done by Sandroni et al.
that explored the application of neuroprognostic tools in patients treated with therapeutic
hypothermia found that the quality of evidence supporting the use of these tools ranged from
“Very Low” to “Moderate”, and that none were good predictors of neurologic recovery. The
authors concluded that in the first 7 days post-arrest, some of these tools, such as a
bilaterally absent N20 somatosensory evoked potential (SSEP) wave or a nonreactive EEG
after rewarming, were useful for predicting poor neurologic outcome, but that these tools
were accompanied by a high risk of bias.3 Unfortunately, many patients have WLST prior to
7 days post-arrest – median time to WLST was only 2 (IQR: 1, 5) days post-arrest in this
study and was previously documented as 3 (IQR:1–5) days in another13 – which results in
decisions prior to the application of these prognostic tools and the possibility of death in a
patient who may have had a different outcome if given further time to awaken or undergo
further neuroprognostic testing.
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Despite the imprecision of post-arrest neuroprognostic tools, many patients who survive
initial resuscitation die as a result of WLST due to suspected neurologic causes. One study,
which looked at the cause of death in ICU-admitted post-arrest patients who died before
hospital discharge, found that suspected neurologic injury was the cause of death in 58/126
non-survivors (46%), which differed based on location of arrest: 68% of patients with out of
hospital arrests had suspected neurologic injury as the cause of death compared to 23% of
patients with in-hospital arrests.7 A similar study looked at 58 patients and found that 40
patients died as a result of withdrawal of life-sustaining therapies, 8 died as a result of brain/
cardiac death, and 10 survived, which means that 83% of non-survivors had WLST—
showing how common this practice is. Another study of 55 TTM-treated patients with
arrests between 2005–2009 found that 57% patients had a negative neurologic prognosis
within 15 h after being rewarmed; 25% of these had WLST prior to 72 h post-arrest. Most
astonishingly, 21% of the patients given a poor prognosis had a good neurologic outcome at
hospital discharge9; showing how important understanding the mechanisms behind WLST is
both to patients and to clinical research.
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As medical resources are finite, it is important to recognize that some post-arrest patients
will not have a reasonable hope of recovery and may not benefit from the continued use of
considerable resources that could be allocated elsewhere. However, there is a lack of
standardized protocol for determining these patients and deciding to withdraw life sustaining
therapy within and between institutions as well as a lack of consensus for what this protocol
should entail. In a large randomized controlled trial (RCT) in Europe examining two
different target temperatures for post-arrest targeted temperature management,3 Nielsen et
al. actively worked to reduce the potential bias by using a protocol across the entire RCT.
This protocol required that all patients be actively treated until 72 h after the intervention
period (108 h post-arrest) and then specified when neurological evaluation would be done on
comatose patients, protocolized what the examination would entail, and documented the
rationale for all WLST,11 showing that it is possible to adopt a well-defined standard
protocol for WLST. Additionally, no patient could have therapy withdrawn for neurologic
reasons prior to 72 h post-arrest, except in cases of cerebral herniation or early myoclonus
status with a negative SSEP.3 This protocol differs vastly from what we found in this study
Resuscitation. Author manuscript; available in PMC 2018 January 01.
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—contrary to waiting 4.5 days prior to beginning to assess patients for WLST as stated in
the protocol, patients had life-sustaining therapies withdrawn a median of 2 days post-arrest,
which is consistent with findings in in-hospital patients.15 This disconnect and the variability
in prac-tice highlights the importance of accounting for WLST and delving further into the
mechanisms behind current practices.
However, a recent multi-center randomized controlled trial aimed at improving adherence to
neuroprognostication protocols showed that a quality improvement intervention increased
rates of appropriate neuroprognostication. Although this trial did not show significant
improvement in survival, it does provide support for the feasibility of successful
implementation of a standardized protocol.16
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Without standardization, the results of cardiac arrest research, especially those with
neurologic status as a primary or secondary outcome, could be severely biased. We have
shown that there is variability of care around WLST, which can lead to self-fulfilling
prophecies in which life-sustaining therapies are withdrawn in patients with the potential to
recover neurologically. This can lead to an overestimation of the ability of a test to predict
bad outcome and affect the modalities used to neuroprognosticate. Neuroprog-nostic tests
are also usually ordered for a specific reason, which could lead to spectrum bias, causing an
over- or under-estimation of the utility of the prognostic tools being applied when making
the decision to WLST. A recent study of 16,875 OHCAs estimated that early withdrawal of
care due to expected poor neurologic prognosis was associated with an annual excess
mortality of 2300 patients in the US, 64% of whom may have had a favorable functional
outcome (as measured by a modified Rankin score 3 at hospital discharge).17 Not accounting
for the effects of WLST ≤ variability is potentially harmful both clinically and in
resuscitation research, especially given our finding that there is a trend over time toward
increased WLST.
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There were multiple limitations in our study; most notably, this investigation was an analysis
of retrospectively collected data. Relying on medical records and documentation with the
purpose of patient care as opposed to research inevitably leads to miss ing data and the
potential for misclassification. Additionally, the use of registry data limits data to only prespecified and defined data points and can lead to a loss of nuance by limiting response
choices. As there is currently no standard practice for WLST and this is a multi-center study,
protocols, practice, and patient composition could vary widely by site and add spurious
heterogeneity, although we did not find significant evidence of this. However, use of a
registry allowed for this evaluation of over 1300 patients at 26 American institutions, the
largest study of WLST in this population. Finally, without thorough documentation of the
processes that went into the decision to withdraw life-sustaining therapies, particularly
because our data set does not delineate which patients had WLST due to neurologic poor
prognosis versus medical futility, we have no way to determine which factors were deemed
important by the healthcare proxy in ultimately deciding whether to withdrawal lifesustaining therapies in a particular patient.
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Conclusions
In conclusion, comatose post-arrest patients who had WLST in the hospital were older, were
more likely to have a longer arrest downtime, be female, have an unwitnessed arrest, and
have COPD, CAD, DM, hypertension, PVD, metastatic cancer, and CHF. They are more
likely to have post-arrest neurology and cardiology consults, less likely to go to the
electrophysiology lab, and have a shorter hospital stay. Further investigation is necessary to
understand the intricacies that contribute to decisions surrounding WLST as well as the
timing of decision in post-arrest patients who remain comatose despite post-cardiac arrest
care.
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Fig. 1.

Post-arrest hospital length of stay by withdrawal of life-sustaining therapies (WLST).
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Fig. 2.

Percentage of patients with withdrawal of life-sustaining therapies by year.
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Comparison of patients with WLST and those who did not have WLST.
WLST (n = 565)

No WLST (n = 746)

p-value

67 (56, 78)

62 (51, 72)

<0.001

White

72.7%

67.0%

Black

21.9%

25.0%

Other

5.4%

8.0%

53.7%

63.1%

0.001

Acute stroke/transient ischemic attack

2.1%

4.3%

0.033

Chronic pulmonary obstructive disorder

11.0%

5.6%

<0.001

Coronary artery disease

18.8%

14.2%

0.026

Dementia

3.0%

1.8%

0.341

Diabetes mellitus

23.1%

16.2%

0.002

Hypertension

33.7%

27.2%

0.012

Cancer

6.6%

3.9%

0.030

Peripheral vascular disease

6.0%

2.9%

0.006

End stage renal disease

5.7%

5.2%

0.682

HIV/AIDS

0.2%

0.0%

0.265

Congestive heart failure

21.1%

12.3%

<0.001

Witnessed

76.4%

83.8%

0.002

Cardiac etiology of arrest

61.8%

72.3%

<0.001

Out-of-hospital arrest

58.6%

62.7%

0.132

VF/VT

24.8%

43.6%

Asystole

30.3%

20.3%

PEA

Age (median [IQR] years)
Race

Male

0.082

Comorbidities

Author Manuscript

Initial rhythm

Author Manuscript

<0.001

Author Manuscript

44.9%

36.0%

Duration of arrest (median [IQR] minutes)

20 (9, 34)

13 (8, 25)

<0.001

Targeted temperature management

54.3%

65.2%

<0.001

Neurology consultation

64.2%

60.2%

0.328

Cardiology consultation

70.9%

81.0%

0.005

Cardiac catheterization lab

19.5%

43.9%

<0.001

Electrophysiology lab

1.5%

8.6%

<0.001

Electroencephalography

52.2%

47.8%

0.301

Head CT scan

58.7%

62.5%

0.383

Brain MRI scan

4.6%

9.5%

0.037

Echocardiography performed

60.2%

72.2%

Hospital length of stay (median [IQR] days)

2 (1, 5)

10 (2, 17)

0.003
<0.001
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Table 2

Author Manuscript

Comparison of patients with WLST in the first 48 h post-arrest and those without WLST/WLST after 48 h
post-arrest.
WLST in 1st 48 h (n = 294)

No WLST or WLST after 48 h (n = 1005)

p-Value

71 (59, 80)

62 (52, 73)

<0.001

White

75.9%

67.5%

Black

18.9%

25.2%

Other

5.2%

7.2%

50.9%

61.2%

0.001

Acute stroke/transient ischemic attack

0.7%

4.2%

0.004

Chronic pulmonary obstructive disorder

7.8%

8.1%

0.902

Coronary artery disease

14.6%

16.7%

0.395

Dementia

2.4%

1.8%

0.474

Diabetes mellitus

18.7%

19.2%

0.843

Hypertension

28.2%

30.2%

0.519

Cancer

7.1%

4.5%

0.071

Peripheral vascular disease

5.1%

4.1%

0.449

End stage renal disease

3.4%

6.1%

0.079

HIV/AIDS

0.3%

0.0%

0.235

Congestive heart failure

17.7%

15.8%

0.438

Witnessed

81.2%

80.5%

0.804

Cardiac etiology of arrest

61.1%

67.8%

0.040

Out-of-hospital arrest

48.0%

64.2%

<0.001

VF/VT

18.8%

40.2%

Asystole

32.8%

22.3%

PEA

48.5%

37.5%

Duration of arrest (median [IQR] minutes)

19 (8, 34)

15 (8, 29)

Targeted temperature management

34.4%

68.0%

<0.001

Neurology consultation

41.3%

67.9%

<0.001

Cardiology consultation

55.8%

80.9%

<0.001

Cardiac catheterization lab

14.0%

38.1%

<0.001

Electrophysiology lab

0.4%

6.9%

<0.001

Electroencephalography

25.7%

56.1%

<0.001

Head CT scan

37.1%

66.4%

<0.001

Brain MRI scan

3.2%

8.0%

0.104

Echocardiography performed

38.0%

73.5%

<0.001

Hospital length of stay (median [IQR] days)

1 (0, 1)

8 (3, 16)

<0.001

Age (median [IQR] years)
Race

Male

0.040

Comorbidities

Author Manuscript
Author Manuscript

Initial rhythm

Author Manuscript
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<0.001

0.048

